Live
FierceBiotechCreate Medicines fashions $122M fundraise for in vivo CAR-T dreamsBioPharma DiveWith new data, Regenxbio to seek FDA approval of Duchenne gene therapyEndpoints NewsHow Penn Medicine plans to use AI to train their doctorsFierceBiotechBiogen advances Alzheimer’s tau program despite midphase missPharmaVoiceFDA chief’s exit clouds already murky drug approvalsJEOLJEOL stock (JP3612800009): Medical equipment business sale to Sysmex marks strategic shift - AD HOC NEWSEndpoints NewsBiogen's anti-tau Alzheimer's drug misses Phase 2 goal, but claims signs of efficacyFierceBiotechAptose, facing cash crunch, exits blood cancer pact after Hanmi buyout blocks developmentFierceBiotechRegenxbio reaps pivotal win for Duchenne muscular dystrophy gene therapyCellTransplantation of encapsulated mitochondria alleviates dysfunction in mitochondrial and Parkinson’s disease modelsEndpoints NewsRegenxbio hits Duchenne gene therapy milestone, eyes 2027 FDA approvalEndpoints NewsBeOne’s next-gen BCL2 inhibitor wins FDA approval, taking aim at Venclexta

Archive

Latest Oldest
Total 11081
Page 439 / 616
Query --